The Ministry of Ayush has signed a host country agreement with the World Health Organization (WHO) for the establishment of a WHO Global Center for Traditional Medicine in Jamnagar, India, with its interim office at the Institute of Ayurveda Training and Research (ITRA) in Gujarat.
The Center will be supported by an investment of approximately $250 million from the Government of India. The main objective of GCTM is to harness the potential of traditional medicine worldwide through modern science and technology and to improve the overall health of communities around the world.
The agreement was signed in Geneva by Vaidya Rajesh Kotecha, Secretary of the Ministry of Ayush and Director General of WHO, Dr Tedros Adhanom Ghebreyesus on March 25.
Prime Minister Narendra Modi, in his message to the event, said, “It is heartening to hear of the signing of the agreement for the establishment of the World Center for Traditional Medicine. Through various initiatives, our government has been tireless in its efforts to make preventive and curative health care affordable and accessible to all. Jamnagar Global Center will help to provide the best healthcare solutions in the world. »
Minister Ayush Sarbanand Sonowal said his ministry was able to achieve this thanks to the initiative and efforts of our illustrious Prime Minister Narendra Modi. He added that the Center will bring tremendous benefits to traditional medicine systems around the world. He informed that the Center will bring the availability of a better system to connect with the latest scientific methods.
Underscoring the importance of the Indian government’s initiative, Dr Tedros Ghebreyesus said harnessing the potential of traditional medicine based on modern science and the principles of equity and sustainability will be a game-changer for the health in the 21st century.
The GCTM will be the first and only global center for traditional medicine in the world. It will focus on building a strong evidence base for policies and standards on traditional medicine practices and products and will support countries to integrate it, where appropriate, into their health systems and regulate its quality and safety for optimal and lasting impact. The WHO-GCTM is designed to engage and benefit all regions of the world.
(Only the title and image of this report may have been edited by Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)